Isabelle Grotte No. 1 Top Producer of Zephyr Real Estate’s Noe Valley Office
Feb 16, 2018 17:00 pm UTC| Business
SAN FRANCISCO, Feb. 16, 2018 -- Isabelle Grotte has achieved No. 1 Top Producer status at the Noe Valley office and No. 2 Company wide. In 2017, she handled 46 closed transactions totaling more than $70 million in sales...
Young Jewish Professionals (YJP) Hosted CEO Healthcare Symposium in New York City
Feb 16, 2018 16:50 pm UTC| Business
NEW YORK, Feb. 16, 2018 -- Young Jewish Professionals (YJP) hosted one of the largest gatherings of C-level executives in the healthcare and pharmaceutical industries during its 2018 CEO Healthcare Symposium. The...
Post Holdings’ Michael Foods Business Announces Plan to Build $85 Million Manufacturing Facility
Feb 16, 2018 16:45 pm UTC| Business
Norwalk, Iowa named site for new pre-cooked egg manufacturing and distribution facilityCreation of 100-150 jobs anticipated Construction to start in summer 2018 ST. LOUIS, Feb. 16, 2018 -- Post Holdings, Inc....
UCL Completes OTC Markets Upgrade
Feb 16, 2018 16:44 pm UTC| Business
TAMPA, Fla., Feb. 16, 2018 -- United Consortium Ltd. (OTC PINK:UCSO), an acquisition and development Company focused on creating shareholder value by identifying and monetizing opportunities in Block Chain, Technology,...
Feb 16, 2018 16:38 pm UTC| Business
NEW YORK, Feb. 16, 2018 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of Delaware on behalf of investors who purchased...
DropCar, Inc. (Nasdaq: DCAR) to Ring The Nasdaq Stock Market Opening Bell
Feb 16, 2018 16:23 pm UTC| Business
ADVISORY, Feb. 16, 2018 -- What: DropCar, Inc. (Nasdaq:DCAR), a provider of automotive vehicle support, logistics and concierge services for both consumers and the automotive industry, will visit the Nasdaq...
AIT Therapeutics Announces $9.82 Million Private Placement
Feb 16, 2018 16:03 pm UTC| Business
NEW YORK, Feb. 16, 2018 -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with serious lung infections and...